AKT1 and neoplasm: Compound R23 inhibits the phosphorylation of downstream proteins AKT and S6 in cells, arrests the cell cycle in G1 phase, and exhibits in vivo antitumor activity in a tumor xenograft A549 model in nude mice [62].